FDA grants emergency authorization allowing monkeypox vaccine by intradermal injection

The Food and Drug Administration granted an emergency authorization that allows healthcare providers to give out the Jynneos monkeypox vaccine to adults intradermally instead of subcutaneously. Injecting the vaccine into an upper layer of the skin is expected to allow more doses of the vaccine developed by Bavarian Nordic BVNRY, -5.97% to be made available to the public during the public health emergency. “Given the continued spread of the monkeypox virus at a rate outpacing the availability of our current vaccine supply, the agency began exploring viable scientific options that would allow for greater access to the currently available vaccine,” FDA Commissioner Robert Califf said Tuesday at a White House briefing. The Centers for Disease Control and Prevention also said it plans to provide educational materials to providers to educate them about how to immunize people using this approach.